Daily Stock List
GelTech Solutions, Inc. (GLTC)
TheMicrocapNews reported previously on GelTech Solutions, Inc. (GLTC), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
GelTech Solutions, Inc. creates unique, Earth-friendly, cost-effective products. All products being marketed by the Company were created for GelTech by inventor and Chief Technology Officer, Mr. Peter Cordani. The Company's products help industry, agriculture, and the public achieve environmental and safety goals including water conservation and protecting lives, homes and property from fires. GelTech Solutions lists on the OTC Markets' OTCQB; the Company has their headquarters in Jupiter, Florida.
GelTech is the creator of Soil2O Dust Control. This is the Company's cost effective, environmentally friendly solution to airborne dust. In addition, they created FireIce, an innovative water enhancing fire suppressant that has the potential to change current firefighting techniques around the world.
Soil2O is a non-toxic soil conditioner and a dust abatement product. Soil2O "Dust Control" products and solutions stop all types of particulate matter from entering the air and water. Soil2O Granular and Topical blends reduce water consumption up to 50 percent. They promote healthy root development in plants and lawns, generating quicker seed germination through keeping nutrients and moisture at the root level for a longer period. The Soil2O water-retaining stabilizer and conditioner can hold up to 400 times its weight. It releases the moisture back to plants' roots only when needed.
FireIce is a patent pending fire suppressant used for direct attack of fires and as a medium term retardant for structure protection. FireIce can be used in all types of apparatus. These include fire extinguishers, pumper trucks, aerial units for wildfires, as well as home defense units for personal home protection.
Yesterday, GelTech Solutions announced that Mr. Peter Cordani, the Company's Chief Technology Officer, recently spent four days in Colombia working with a large private international mining company to help them mitigate dust from the haul roads. GelTech Solution's Soil2O Dust Control product was chosen over two other competing products in side by side testing.
GelTech Solutions, Inc. (GLTC), closed Wednesday's trading at $0.99, up 5.32%, on 104,351 volume with 53 trades. The average volume for the last 60 days is 84,234 and the stock's 52-week low/high is $0.21/$1.75.
Discovery Laboratories, Inc. (DSCO)
StreetInsider reported yesterday on Discovery Laboratories, Inc. (DSCO), WiseAlerts, MonsterStocksPicks, Stock Stars, The Motley Fool, FeedBlitz did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Discovery Laboratories, Inc. is a specialty biotechnology company whose commitment is to advancing a new standard in respiratory critical care through the development of novel technologies. The Company is concentrating on two primary areas of development. One is their proprietary KL4 surfactant technology. The second is their novel drug delivery technologies to deliver aerosolized respiratory medicines, including the Company's KL4 surfactant. Discovery Laboratories has their headquarters in Warrington, Pennsylvania.
Their novel proprietary KL4 surfactant technology produces a synthetic, peptide-containing surfactant. It is structurally comparable to pulmonary surfactant. Discovery Laboratories' strategy is first focusing on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. AEROSURF (lucinactant for inhalation), their initial aerosolized KL4 surfactant product, is under development to address respiratory distress syndrome in premature infants.
The Company's products include SURFAXIN®. SURFAXIN (lucinactant) intratracheal suspension is a synthetic, peptide-containing surfactant. SURFAXIN is indicated for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.
Their products also include AFECTAIR. The development of the AFECTAIR technology was as a proprietary, disposable device that simplifies the delivery of aerosolized medications to critical-care patients requiring ventilatory support including intermittent mechanical ventilation or continuous positive airway pressure. The Company is also pursuing European Conformity (CE) marking for potential commercialization of AFECTAIR for infants in the European Union (EU) this year.
This week, Discovery Laboratories announced that the U.S. Food and Drug Administration (FDA) has requested clarification and provided recommendations regarding the recently updated product specifications for SURFAXIN®. Discovery Labs plans to provide a response to the FDA within two months. FDA procedure provides up to four months for FDA review of the information provided. If their plan is successful and the FDA agrees with the response, Discovery Labs expects to proceed with the commercial introduction of SURFAXIN in the fourth quarter of 2013.
Discovery Laboratories, Inc. (DSCO), closed Wednesday's trading session at $1.76, down 0.56%, on 747,787 volume with 2,271 trades. The average volume for the last 60 days is 269,681 and the stock's 52-week low/high is $1.71/$3.51.
CirTran Corp. (CIRC)
UltimatePennyStock and OTCPicks reported earlier on CirTran Corp. (CIRC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 1993, CirTran Corp. provides total product development and manufacturing services for a broad spectrum of business sectors. The Company's roots are as an international, full-service contract manufacturer. Based in Salt Lake City, Utah, the Company operates along with their Racore Technology electronics manufacturing subsidiary. They operate from an ISO 9001:2000-certified facility. CirTran's operations include CirTran-Asia, CirTran Online, and CirTran Beverage. The Company's shares trade on the OTC Markets' OTCQB.
Their CirTran-Asia subsidiary has principal offices in ShenZhen, China. They manufacture high-volume electronics, fitness equipment, and household products for the multi-billion-dollar direct response industry. Their CirTran Online offers products directly to consumers by way of major retail web sites. Their CirTran Beverage has partnered with Play Beverages, LLC, to introduce and distribute the Playboy Energy Drink.
During 2012, CirTran established operations and gained new revenue in Asia. This included China, the Middle East, and Africa, among other areas. Operations continued in the United States, South America, Europe and Canada. CirTran had beverage distribution operations in more than 20 countries, entering 2013.
Today, CirTran announced that they filed their Form 10-K for the fiscal year ended December 31, 2012. The Company reported a significant expansion in sales and an even greater improvement in bottom line results driven by their Playboy Energy Drink line of products. Revenues from beverage distribution increased to $4,260,417. This represents a 39 percent gain over the $3,064,438 reported for fiscal year 2011. Revenues from beverage distribution accounted for 98 percent of sales during 2012.
The Company reported a loss from operations of $375,813 for fiscal 2012. This represents an improvement of over 94 percent from a loss of $6,575,219 reported a year prior. Overall, they reported a net loss of $1,787,643 for fiscal year 2012. This represents a 75 percent improvement from a loss of $7,043,410 reported a year prior.
CirTran Corp. (CIRC), closed Wednesday's trading session at $0.0008, even for the day, on 19,784,338 volume with 64 trades. The average volume for the last 60 days is 30,601,212 and the stock's 52-week low/high is $0.0002/$0.0039.
Force Energy Corp. (FORC)
MyBestStockAlerts, PennyStockClub, The Stock Scout, Penny Stock Pros, StockMister, Liquid Tycoon, WePickPennyStocks, Winning Penny Stock Picks, Super Nova Stock Picks, Penny Stock Pick Report, PennyStockPickAlert, Super Hot Penny Stocks, PennyStockMoneyTrain, Wallstreetlivechat, and Penny Stock Rumble reported recently on Force Energy Corp. (FORC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 2006, Force Energy Corp. is a Lithium and Hydrocarbon Exploration and Development Company. The Company's intention is to explore and develop their Zoro 1 Lithium property located in the Snow Lake area of west-central Manitoba, Canada. In addition, they maintain a 50 percent working interest in the Hayter Well, located in the Province of Alberta. Force Energy has their corporate headquarters in Denver, Colorado.
The Company's Zoro 1 property is a 52-hectare (128 acre) tract of land situated close to the East Shore of Wekusko Lake in west-central Manitoba. The Zoro 1 property hosts multiple rare metal spodumene pegmatite dykes. The main masses of spodumene-bearing zones are exposed in seven main trenches. The seven pegmatite dykes were exposed by a series of seven main trenches and 78 diamond drill holes during historic exploration.
Drilling indicated Lithium mineralization on this property coupled with data from trenching indicate total undiluted tonnage given as 1,727,550 tons of the Lithium bearing mineral which assays at 0.945 percent Lithium Dioxide. The Company maintains a 100 percent working interest in the Zoro 1 Lithium Property. Force Energy indicates that the deposits are of significant merit. However, they will require further exploration and work.
Concerning the Hayter Well, County Line Energy Corp. is the operator of the well. The Hayter well has undergone casing and cementing in anticipation of the completion of the drill program. County Line Energy's intention is to enter the Hayter well, perforate the potential pay zones, and conduct regular production testing of the zones.
Should the testing confirm sufficient oil reserves and potential economic flow rates, the expectation is that County Line will install adequate pumping equipment and other surface facilities in anticipation of the projected flow rates. At present, there exist no known oil reserves on the Hayter well.
Force Energy does not anticipate immediate attention to the Hayter Well project. The Company is currently focusing their time and effort on their Zoro 1 Mineral Claim.
Force Energy Corp. (FORC), closed Wednesday's trading session at $0.0042, up 16.67%, on 7,771,652 volume with 7 trades. The average volume for the last 60 days is 2,755,448 and the stock's 52-week low/high is $0.0025/$0.0535.
Stakool, Inc. (STKO)
PennyStocks24 reported recently on Stakool, Inc. (STKO), Wallstreetlivechat, OTCPicks did earlier, and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Stakool, Inc. supplies natural and organic health and wellness products. Headquartered in Jacksonville, Florida, the Company's commitment via their wholly owned subsidiary, Anthus Life Corp., is to being a foremost North American supplier of natural and organic and health and wellness products. Anthus Life brings to market complementary products that are most suited to the consumer. Stakool's shares trade on the OTC Markets' OTCQB.
The Company's Anthus Life product line includes eight health bars that have no refined sugar, no artificial flavors, low sodium, no genetically modified products, no preservatives, no trans fat, no gluten, no cholesterol, no dairy products, and no wheat. These bars are a nutrient dense food snack, which assists in sustaining energy.
Stakool's mission is to implement strategies to greatly increase the distribution of their "Natural plus Energy" healths bars as well as pursue other opportunities. Their Anthus Life will continue to work to introduce additional USDA Certified Organic health products. Their research and development (R&D) team is working to develop additional product line extensions to include but not limited to energy drinks, additional health food items, snacks, cookies, as well as the potential integration of advanced technologies such as nutraceuticals, and more.
Anthus Life will establish a procurement program. They will work with outside professionals to build their business, create brands through eco friendly packaging and distinctive labeling, and develop key distribution relationships.
Today, Stakool announced the appointment of Mr. Kevin P. Quirk, effective April 20, 2013, as Chief Executive Officer and Member of the Board. Mr. Quirk has more than 20 years of general, brand and financial management experience along with expertise in raising capital in the consumer products and home healthcare industries. He founded White Hat Brands, a health and wellness beverage company. He later oversaw the sale of White Hat, which sold privately for approximately $30,000,000.
Mr. Joseph Canouse, Chairman, said, "The Corporation is excited to bring an executive with Mr. Quirk's experience to develop and implement strategies to becoming a leading innovator in the multi-billion dollar health and wellness sector. He has been successful with Fortune 100 Companies as well as start-ups wearing many hats."
Stakool, Inc. (STKO), closed Wednesday's trading session at $0.0005, up 150.00%, on 283,244,312 volume with 259 trades. The average volume for the last 60 days is 58,507,170 and the stock's 52-week low/high is $0.0001/$0.0093.
Arctic Star Exploration Corp. (ADD.V)
Today we are reporting on Arctic Star Exploration Corp. (ADD.V), here at the QualityStocks Daily Newsletter.
Arctic Star Exploration Corp. is a junior natural resource company with corporate headquarters in Vancouver, British Columbia (B.C.). They engage in the acquisition, exploration, and development of diamond and nickel properties in Canada. The Company was formerly known as Arctic Star Diamond Corp. They changed their name to Arctic Star Exploration Corp. in July of 2011. Arctic Star Exploration's rare earths project in British Columbia is the CAP property.
The Company's three rare earth properties are in the Carbo area of northeastern B.C. The Cap, Seebach and Javorsky rare earth element (REE) and rare metal properties are all within the immediate vicinity of Spectrum Mining Corp.'s Wicheeda REE Discovery and the Carbo Project. The group of claims is 80 km northeast of Prince George and together consists of 20 mineral claims covering approximately 9,129 hectares.
CAP lies on the same geological belt approximately 50 km NE of Prince George within an emerging Alkaline-Carbonatite Rare Earth Element district. The Cap Property consists of five claims totaling 2,354 hectares.
Arctic Star also previously acquired a gold-copper exploration project called "El Havila", in Colombia, South America. The property shares the same geological belt as Ventana Gold's La Bodega project. Earlier assays from a sampling program by Arctic Star at El Havila ran up to 19.3 g/t Gold on a grab sample. Arctic Star has an option to earn an 85 percent interest on the Property by making US$5,000,000 in exploration expenditures over a 3-year period. The Company's interest in the Property can be increased to 95 percent by the payment to the Property vendor of 15,246 troy ounces of gold. The Property vendor would retain a 5 percent free carried interest.
This past January, Arctic Star Exploration reported on their plans to reignite their diamond exploration activities in the Lac de Gras diamond fields in the Northwest Territories (NWT), Canada. Their focus involves recently staked claims in the Lac de Gras area that were acquired. These claims are at the head of Arctic's prominent diamond indicator mineral train just to the east of the project area that was extensively explored by Arctic Star between 2004 and 2010.
Yesterday, Arctic Star Exploration announced that they engaged the services of Peak Drilling. The drill rig and crew have mobilized to the 100 percent owned Redemption Diamond Project located in the Lac de Gras diamond fields. Several strong Geophysical targets will be drill tested. One is at the head of the South Coppermine Diamond Mineral train.
Arctic Star Exploration Corp. (ADD.V), closed at $0.28, down 1.75%, on 250,880 volume. The stock's 52-week low/high is $0.14/$0.31.
Fission Energy Corp. (FIS.V)
Stockhouse and Streetwise Reports reported earlier on Fission Energy Corp. (FIS.V), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Based in Kelowna, British Columbia, Fission Energy Corp. is a resource company specializing in the strategic acquisition, exploration and development of uranium properties. The Company has properties in Saskatchewan's Athabasca Basin, and in the Province of Quebec, the Hornby Basin of Nunavut, as well as in Namibia and the Macusani District of Peru. Fission Energy's principal exploration focus is Saskatchewan's Athabasca Basin. The Company's shares trade on the TSX Venture Exchange.
The Athabasca Basin is the home of the richest uranium mines in the world. In addition, the Dieter Lake deposit, located in Quebec, is a significant uranium property with a large tonnage, low grade, NI 43-101 compliant Inferred resource. The majority of Fission Energy's exploration properties in these two regions were acquired by staking in 2003-2004.
Fission Energy is exploring at two core projects in the Athabasca Basin. One is their flagship Waterbury Lake project. The second is their emerging Patterson Lake South project (PLS). The 31,039 hectare PLS project is a 50-50 Joint Venture held by Fission Energy and Alpha Minerals, Inc. (AMW.V). Fission Energy is the Operator.
Yesterday, Fission Energy and their Joint Venture partner Alpha Minerals announced results from the final 10 drill targets from the Winter 2013 exploration program at the Patterson Lake South (PLS) property. The final 10 holes to report consist of six holes from the R00E Zone, 2 holes from the R390E Zone and 2 holes testing regional targets.
Further drilling at the R00E zone has extended the strike length of high-grade mineralization for greater than 120m at widths of up to 50m. R00E is one of three broad, shallow-depth discovery zones identified along approximately 850m overall strike length during the winter drilling; it remains open along strike and width.
The winter drill program, which has totaled 10,182.6m in 46 completed drill-holes, is now complete. Additional drilling is needed to continue to delineate the mineralized areas. Radon surveying began in February.
Fission Energy Corp. (FIS.V), closed Wednesday's session at $0.84, down 5.62%, on 632,293 volume. The stock's 52-week low/high is $0.34/$1.26.
Universal Bioenergy, Inc. (UBRG)
Stock Analyzer, pastwellness.com, Investor News Source, and Stock Alerts reported earlier on Universal Bioenergy, Inc. (UBRG), and today we are reporting on Universal Bioenergy, Inc. (UBRG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Universal Bioenergy, Inc. is an independent diversified energy company. They market natural gas, petroleum, coal, and propane. In addition, the Company engages in the acquisition and development of existing or recently discovered oil and gas fields, leases and surface coalmines. The Company was formerly known as Palomine Mining, Inc. They changed their name to Universal Bioenergy, Inc. in October of 2007. Universal Bioenergy is based in Irvine, California.
The Company markets energy resources to the largest public utilities, electric power producers and local gas distribution companies in the U.S. These entities serve millions of commercial, industrial and residential customers.
Universal Bioenergy previously announced that their subsidiary NDR Energy Group's new Electric Power Division is operational and is preparing to begin marketing electric power. On February 12, 2013, the Company announced NDR Energy received final approval for their "Power Marketing License" from the Federal Energy Regulatory Commission (FERC). With that approval, NDR Energy could commence selling electric power right away. Universal Bioenergy forecasts that sales of electricity are projected to generate an estimated $96 to $384 million in additional revenue for the Company.
Universal Bioenergy also recently announced that the Company's management team for their global coal division is in negotiations with many companies to arrange the logistics and transportation for the sales of coal to their Asia and Europe customers. The Company and their transportation consultants are negotiating terms and pricing with a number of railroad companies to ship the coal from the load-out facilities at the mines and transport it to the various seaport terminals.
Furthermore, two weeks ago, Universal Bioenergy announced that they are in advanced negotiations for an agreement with a company in China to sell them large quantities of high thermal steam coal for electric power production. The expectation is that the agreement will have provisions to grow coal sales from $108 to $270 million annually based on their increasing demand.
Universal Bioenergy's intention is to sell an estimated 1,200,000 to 3,000,000 tons of high-grade thermal steam coal annually for the next 3 years for export to the company in China. The total estimated amount of coal to undergo delivery for the next 3 years is 3,600,000 to 9,000,000 tons (at an estimated $90.00 per ton). The total estimated value of the transaction is $324 to $810 million over the next 3 years.
Today,Universal Bioenergy, Inc. (UBRG), closed Wednesday's trading session at $0.003, down 14.29%, on 17,160,004 volume with 128 trades. The average volume for the last 60 days is 9,322,333 and the stock's 52-week low/high is $0.0019/$0.0333.
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.015, off by 1.32%, on 329,649 volume with 16 trades. The stock’s average daily volume over the past 60 days is 851,924, and its 52-week low/high is $0.0013/$0.0158.
Viaspace, Inc. announced a meeting today between CEO Dr. Carl Kukkonen and Grain Hill CEO and Board President, Amilcar Ybarra-Rojas, as well as his team, in Nicaragua last week to look at the Giant King Grass being grown on their lands as per the previously signed contract between the two companies. Plans are to expand to fully support a 2,100-acre plantation of the biomass marvel, which is growing exceptionally well in the Venezuelan climate, in order to feed a proposed partnership between VSPC and Grain Hill subsidiary, AGRICORP, that would construct a 12 MW biomass power plant.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE and AGRICORP Partnership on Giant King Grass in Nicaragua: 12 MW Biomass Power Plant Targeted
VIASPACE Insiders Extend Lock-up of Shares
VIASPACE Chairman Interviews with CEONEWS.Tv Regarding Business Dynamics and Recent Corporate Milestones
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.08, even for the day, on 1,686,416 volume with 102 trades. The stock’s average daily volume over the past 60 days is 3,437,242, and its 52-week low/high is $0.0275/$0.155.
Advaxis, Inc. reported selection of two of the company's abstracts on their lead clinical stage product candidate, ADXS-HPV (ADXS11-001), for presentation at this year's American Society of Clinical Oncology Annual Meeting, to be held in Chicago this year, from May 31 to June 4, at the McCormick Place Convention Center. This first abstract looks at groundbreaking work in India done in ADXS11-001 immunotherapy targeting recurrent/refractory cervical cancer and the second covers trial design for ongoing Phase 2 work by the Gynecologic Oncology Group here in the United States.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis to Report 12-Month Survival from Its Phase 2 Study of ADXS-HPV in Women with Recurrent/Refractory Cervical Cancer
Advaxis Announces Abstract Accepted for Oral Presentation at SITC Cancer Immunotherapy Clinical Trials Workshop
Advaxis Nominated for Best Early-Stage Vaccine Biotech at 6th Annual Vaccine Industry Excellence Awards
VentriPoint Diagnostics Ltd. (VPTDF)
The QualityStocks Daily Newsletter would like to spotlight VentriPoint Diagnostics Ltd. (VPTDF). Today, VentriPoint Diagnostics Ltd. closed trading at $0.095, off by 9.44%, on 30,000 volume with 4 trades. The stock’s average daily volume over the past 60 days is 29,181, and its 52-week low/high is $0.073/$0.1721.
VentriPoint Diagnostics Ltd. announced today that they have landed the CE Mark for their NRV™ application for the analysis of 2-D ultrasound images in patients with non-specific heart disease via European Notified Body, Intertek Semko AB. This is a big leap forward for clinicians who can use NRV to rapidly and more importantly, accurately assess the status of the right ventricle in patients without congenital heart defects or pulmonary hypertension, yet may have several other conditions, including left-heart failure or valve disease. This application changes everything for cardiologists on the widespread VMS-2DE heart analysis platform and means they can easily examine every patient they see due to rapidity and ease of use.
VentriPoint Diagnostics Ltd. (VPTDF) leverages knowledge-based techniques to make heart analysis more convenient and less expensive. Having already installed multiple VMS™ analysis systems for heart testing in leading cardiac centers in Europe, Canada and the United States, the company is currently focused on expanding the applications of its technology beyond congenital heart disease in adults and children.
VMS™ is the first cost-effective and accurate diagnostic tool for measuring right ventricle heart function. The company designed its analysis system to be used for all major heart diseases, including pulmonary hypertension, cardiovascular disease, and heart failure. Canada and Europe (CE Mark) have granted approval for the sale of the VMS™ diagnostic tool, and VentriPoint is pursuing the US-FDA approval through the 510(k) process.
The company’s VMS™ analysis systems eliminate all the disadvantages of an MRI scan, including a long wait list, the one-hour scan time, the claustrophobic environment, the requirement of a general anesthetic for children, the lengthy heart analysis process, and the need for a second trip to the hospital. Offering better efficiency and cost savings, VMS™ offers the healthcare industry a superior method of heart visualization.
The management team executing VentriPoint’s business strategy retains extensive experience in both healthcare technology and business development. Many expansion opportunities exist for the company’s technology with a total market potential exceeding $1 billion. As a leader in the clinical diagnostics market, the company is well positioned to meet the well-defined clinical need for efficient, accurate, and inexpensive heart analysis. Disclaimer
VentriPoint Diagnostics Ltd. Company Blog
VentriPoint Diagnostics Ltd. News:
VentriPoint Receives CE Mark for Major Expansion of Its VMS™ Platform for Right Heart Analysis
VentriPoint Applies for European and Canadian Approvals for A New Application for Non-Specific Heart Disease
VentriPoint Announces $2 Million Unit Private Placement
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $0.50, on 172,066 volume with 55 trades. The stock’s average daily volume over the past 60 days is 55,338, and its 52-week low/high is $0.25/$1.25.
The Aristocrat Group Corp. kicked off work this week on a new social media app for the Apple device market that is set to reach $25B this year, designed to bring cocktail fans and mixologists together as a way of promoting the new line of spirits coming out of Luxuria Brands, the company's brand management division. This is a perfect way to engage consumers and generate buzz during the roll out of the company's premium vodka and will likely be offered as a free app to drive social circles to locations where Luxuria Brands are made available. The company is looking to engage retail partners with timed events using the app and driven by localized market topology, based on actual social circles and club behavior.
The Aristocrat Group Corp. (ASCC) is a brand management company focused on providing premiere luxury goods through continual innovation. Luxuria Brands, a subsidiary of The Aristocrat Group, has been established to identify and promote unique brands that have mass market appeal across a diverse demographic.
Luxuria Brands is primarily concentrated on distilled spirits industries, with an initial focus on Vodka branding and marketing. The worldwide distilled spirits market is currently worth about $263 billion. In the U.S. alone, Vodka sales between 2004 and 2009 grew 25% from 13.9 million cases to 58.4 million cases. The clear liquor now accounts for almost a third of all distilled spirits consumed and continues to rise in popularity.
The Aristocrat Group is also pursuing opportunities in the women’s lifestyle industry. The World Bank recently estimated that the earning power of women will reach $18 trillion by 2014, which is twice the estimated 2014 GDP of China and India combined. The Aristocrat Group is working to bring fresh, innovative prenatal and postpartum solutions to women who are looking for a more comprehensive approach to wellness.
The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. The company aims to take a leadership position in multiple growing markets that offer opportunities for partnership, sponsorship, and brand awareness activities. The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC Looks to Apple, Social Media to Promote New Brands
ASCC Seeks to Add New Brands Through Mergers & Acquisitions
ASCC to Redefine Spirits Market
Today before the opening bell, VIASPACE reported that CEO Dr. Carl Kukkonen met with Grain Hill CEO and Board President, Amilcar Ybarra-Rojas, and his team in Nicaragua last week. VIASPACE is a contract with AGRICORP, a Grain Hill subsidiary, and is growing its Giant King™ Grass on land owned by them. The Giant King Grass is growing well, and VIASPACE and AGRICORP have agreed to form a partnership to build a 12 MW biomass power plant fueled by the proprietary energy crop.
Grain Hill is a diversified agro-industrial business group engaged in the following food-related businesses: growing rice, food processing, rice milling, and distribution of its own 12 brands of rice, value-added food products, and third-party brands. The company generates annual revenues of $300 million and has operations in Nicaragua, Costa Rica, and El Salvador. Grain Hill/AGRICORP is the largest rice company in Nicaragua with 65% market share.
Giant King Grass is currently being grown on a 10,000-acre AGRICORP farm near Lake Nicaragua. Now that Giant King Grass has proven itself on the AGRICORP plantation, VIASPACE and AGRICORP plan to expand the nursery in May to support the 2,100-acre Giant King Grass plantation needed to fully fuel the 12 MW power plant.
According to today’s press release, VIASPACE and AGRICORP plan to begin development of the power plant project immediately. VIASPACE anticipates a quick return to Nicaragua to kick off the partnership and to join AGRICORP in meetings with electricity customers, the Nicaragua grid company, EPC contractors, banks, and with Nicaraguan government officials.
VIASPACE CEO Dr. Carl Kukkonen stated, “This is a very exciting partnership. VIASPACE will take the lead in project development, Giant King Grass, power plant technology selection, and financial modeling. AGRICORP will lead the interface with the power customer, grid connection, plantation operations and plant permitting. The companies will work closely together and expect to form a special purpose company for the power plant.”
Grain Hill CEO and Board President, Amilcar Ybarra-Rojas commented, “We believe that Giant King Grass has an important role to play in Nicaragua. The new, highly efficient 12 MW power plant will provide clean and steady base power for the country in contrast to intermittent power from wind and solar. It will efficiently use Nicaragua’s natural resources of land, warm weather and water to produce reliable green electricity for our people and industrial development. It will also provide jobs for farmers and power plant workers. Giant King Grass as a dedicated energy crop can also complement sugarcane bagasse as a fuel for existing power plants connected to sugar mills to extend their season and produce more electricity. I believe that this project will add considerable value to our company that has a mandate for agricultural innovation and sustainability.”
For more information on VIASPACE and its Giant King Grass, visit www.VIASPACE.com
Advaxis, a clinical-stage biotech company developing next generation immunotherapies for cancer and infectious diseases, will exhibit two abstracts related to ADXS-HPV (ADXS11-001), the company’s lead clinical stage product candidate, in a poster presentation at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL, from May 31 – June 4, 2013, at the McCormick Place Convention Center.
Abstract #5529, titled “ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a P2 study in Indian women with recurrent/refractory cervical cancer,” was selected for presentation at the Poster Discussion Session: Gynecologic Cancer. This poster will include updated safety, tumor response, and survival data from the ongoing randomized phase 2 trial of ADXS-HPV with or without cisplatin being conducted by Advaxis in India.
Abstract #TPS3121, titled “A phase 2 study of live-attenuated Listeria monocytogenes immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265),” will be presented during the Developmental Therapeutics – Immunotherapy Trials in Progress General Poster Session. This poster will describe the trial design for the ongoing phase 2 study being conducted by the Gynecologic Oncology Group (GOG) in the United States.
“We are pleased to have the opportunity to present the final 12-month survival and other relevant data from our 110 patient trial of ADXS-HPV in recurrent/refractory cervical cancer at ASCO’s annual meeting,” Dr. Robert Petit, vice president of Clinical Operations and Medical Affairs at Advaxis stated in the press release. “ADXS-HPV immunotherapy offers the promise of an effective and well-tolerated treatment for cervical cancer that employs the patient’s immune system to fight the cancer. We are encouraged by the interest that our colleagues in GOG have in joining our efforts to evaluate the potential of ADXS-HPV in cervical cancer, through the conduct of GOG-0265.”
Abstracts will be released on www.asco.org at 6 p.m. May 15, 2013.
For more information, visit www.advaxis.com
Today, VentriPoint Diagnostics, developer of ultrasound tools used on patients with heart disease, announced that the European Notified Body, Intertek Semko AB, has granted a CE Mark for its NRV™ application, which pertains to the analysis of 2-D ultrasound images for patients with non-specific heart disease. The application will allow clinicians to rapidly and accurately assess the status of the right ventricle in patients without significant congenital heart defects or pulmonary hypertension, but who may have a variety of other conditions (such as left-heart failure or valve disease).
The NRV™ database can be used in conjunction with the VMS-2DE™ heart analysis system in instances when knowledge of the function of the right heart is useful in assessing overall heart function. The VMS-2DE™ is approved for clinical use in Europe and Canada. In the United States, the system is currently available for investigational use only.
Adding the NRV™ application to the VMS™ heart analysis systems provides a direct avenue for clinicians to better evaluate and care for individuals currently suffering from some form of heart disease. The application may also be used to provide a reference baseline study for patients at risk for developing right-heart dysfunction, who may benefit greatly from frequent monitoring.
“Leading cardiologists, who have the VMS-2DE™ heart analysis system, have been requesting the NRV™ application so they can examine almost every patient they see,” remarked VentriPoint’s CEO, Dr. George Adams. “This approval will allow our sales force to offer this major expansion of the capability of the VMS-2DE™ to our existing and pending customers in Europe, where heart disease remains the leading cause of death at a financial cost of 196 billion Euros each year.”
VentriPoint also announced that its quality management system has passed the annual surveillance audit and has received renewal compliance certificates for ISO 13485:2003/CMDCAS and MDD 93/42/EEC – Annex II standards. These certificates are required to maintain the company’s licenses to sell medical devices in Europe and Canada.
For more information on VentriPoint and its leading-edge technology, visit www.ventripoint.com
The Aristocrat Group today reported that it has begun working on a new social media app for Apple (AAPL) devices to connect with cocktail fans and mixologists and promote new spirits carried by the company’s brand management division, Luxuria Brands.
ABI Research projects the mobile app economy will reach $25 billion this year. ASCC aims to participate in this rapidly growing market, spreading the word about its upcoming vodka lines slated for production later this year. The company plans to release a free mobile application that will drive social circles of vodka drinkers to bars and liquor stores that carry Luxuria Brands.
“Social networking apps are a fun and effective way to engage with our customers and reward brand loyalty,” said ASCC CEO Robert Federowicz. “We’re working on an app that will allow us to push unique, personalized offers and promos to specific social networks of vodka afficianados and then measure the success of each promotion. We want our retail partners to be able to create events at specific times based on a given social circle or club’s behavior.”
ASCC sees vodka, America’s best-selling spirit, as the key to growing its brand management division.
For more information, visit www.luxuriabrands.com/investors.html
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) to Report 12-Month Survival from Its Phase 2 Study of ADXS-HPV in Women with Recurrent/Refractory Cervical Cancer
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Receives ISO Certification for Excellagen
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- International Stem Cell Corp. (ISCO) Announces Fourth Quarter 2012 Financial Results and Provides Business Update
- Loans4Less.com, Inc. (LFLS) Ranked in List as a Top Residential Loan Originator 2012
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) Nears Deal With Leading Genetic Testing Lab
- Soul and Vibe Interactive Inc. (SOUL) to Pursue Business Development Deals at Game Connection Conference in San Francisco
- The Aristocrat Group Corp. (ASCC) Looks to Apple, Social Media to Promote New Brands
- The Guitammer Company Inc. (GTMM) Joins D-Tools Manufacturer Vantage Point (MVP) Program
- VentriPoint Diagnostics Ltd. (VPTDF) Receives CE Mark for Major Expansion of Its VMS™ Platform for Right Heart Analysis
- Viaspace, Inc. (VSPC) and AGRICORP Partnership on Giant King Grass in Nicaragua: 12MW Biomass Power Plant Targeted
- VistaGen Therapeutics, Inc. (VSTA) Announces $36 Million Strategic Financing Agreement